These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5770437)

  • 1. The detection of neutralizing antibody to lymphocytic choriomeningitis virus in mice.
    Hotchin J; Benson L; Sikora E
    J Immunol; 1969 May; 102(5):1128-35. PubMed ID: 5770437
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific cytotoxic T cells eliminate B cells producing virus-neutralizing antibodies [corrected].
    Planz O; Seiler P; Hengartner H; Zinkernagel RM
    Nature; 1996 Aug; 382(6593):726-9. PubMed ID: 8751445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody.
    Seiler P; Senn BM; Bründler MA; Zinkernagel RM; Hengartner H; Kalinke U
    J Immunol; 1999 Apr; 162(8):4536-41. PubMed ID: 10201992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neutralization test for lymphocytic choriomeningitis virus for distinguishing between two arenavirus infections in Argentina].
    Ambrosio AM; Riera L; Saavedra MC; Sottosanti JJ
    Rev Argent Microbiol; 2001; 33(4):235-40. PubMed ID: 11833256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment and delay of neutralizing antiviral antibody responses by virus-specific cytotoxic T cells.
    Battegay M; Moskophidis D; Waldner H; Bründler MA; Fung-Leung WP; Mak TW; Hengartner H; Zinkernagel RM
    J Immunol; 1993 Nov; 151(10):5408-15. PubMed ID: 7693811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Herpes simplex and lymphocytic choriomeningitis viruses in infections of the central nervous system--clinical and cerebrospinal fluid characteristics].
    Turkulov V; Madle-Samardzija N; Ilić A; Vukadinov J; Canak G
    Med Pregl; 1998; 51(9-10):436-40. PubMed ID: 9863335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing antibody complex of infectious bronchitis virus.
    Stinski MF; Cunningham CH
    J Immunol; 1969 Mar; 102(3):720-7. PubMed ID: 5773320
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased tumorigenesis of murine sarcoma virus (Moloney) by coinfection with Rauscher virus or by treatment with antilymphocyte serum.
    Hook WA; Chirigos MA; Chan SP
    Cancer Res; 1969 May; 29(5):1008-12. PubMed ID: 5781092
    [No Abstract]   [Full Text] [Related]  

  • 9. Methods for detection of antibody to the mammary tumor virus.
    Fink MA; Feller WF; Sibal LR
    J Natl Cancer Inst; 1968 Dec; 41(6):1395-400. PubMed ID: 4302576
    [No Abstract]   [Full Text] [Related]  

  • 10. Public, private and non-specific antibodies induced by non-cytopathic viral infections.
    Recher M; Hunziker L; Ciurea A; Harris N; Lang KS
    Curr Opin Microbiol; 2004 Aug; 7(4):426-33. PubMed ID: 15358263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus.
    Eschli B; Zellweger RM; Wepf A; Lang KS; Quirin K; Weber J; Zinkernagel RM; Hengartner H
    J Virol; 2007 Nov; 81(21):11650-7. PubMed ID: 17699567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 6. IMMUNITY CONFERRED ON TOLERANT MICE BY IMMUNE SERUM AND BY GRAFTS OF HOMOLOGOUS LYMPHOID CELLS.
    VOLKERT M; LARSEN JH
    Acta Pathol Microbiol Scand; 1965; 63():172-80. PubMed ID: 14295436
    [No Abstract]   [Full Text] [Related]  

  • 13. Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection.
    Oldstone MB; Buchmeier MJ; Doyle MV; Tishon A
    J Immunol; 1980 Feb; 124(2):831-8. PubMed ID: 6444319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+ T-cell-epitope escape mutant virus selected in vivo.
    Ciurea A; Hunziker L; Martinic MM; Oxenius A; Hengartner H; Zinkernagel RM
    Nat Med; 2001 Jul; 7(7):795-800. PubMed ID: 11433343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of antibody titers to bovine viruses in rabbit sera.
    Descoteaux JP; Whissel K; Assaf R
    Lab Anim Sci; 1980 Jun; 30(3):581-2. PubMed ID: 6253745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific cytotoxic T cells eliminate cells producing neutralizing antibodies.
    Planz O; Seiler P; Hengartner H; Zinkernagel RM
    Nature; 2003 Nov; 426(6965):474. PubMed ID: 14647387
    [No Abstract]   [Full Text] [Related]  

  • 18. Response of weanling random-bred mice to inoculation with minute virus of mice.
    Smith AL
    Lab Anim Sci; 1983 Feb; 33(1):37-9. PubMed ID: 6339807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralization of animal virus infectivity by antibody.
    Reading SA; Dimmock NJ
    Arch Virol; 2007; 152(6):1047-59. PubMed ID: 17516034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Virological control of laboratory mice].
    Guillon JC
    Acta Zool Pathol Antverp; 1975 Nov; (63):47-59. PubMed ID: 821324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.